Stay updated on Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A new version entry was added to the Record History, showing an updated submission date. No core study data appear to be altered.
    Difference
    0.0%
    Check dated 2025-10-28T05:22:27.000Z thumbnail image
  3. Check
    30 days ago
    Change Detected
    Summary
    - Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.
    Difference
    7%
    Check dated 2025-10-06T16:28:51.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T10:19:50.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; 'Back to Top' removed—a minor UI cleanup with no substantive content changes.
    Difference
    0.4%
    Check dated 2025-09-14T00:24:42.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.4%
    Check dated 2025-09-06T21:08:25.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's content.
    Difference
    100%
    Check dated 2025-08-30T15:32:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.